What Is Tirzepatide (Mounjaro / Zepbound)?
Tirzepatide is the active molecule in Mounjaro® (type 2 diabetes) and Zepbound® (obesity). Unlike Semaglutide which targets only GLP-1, Tirzepatide acts on both GLP-1 and GIP receptors — creating a stronger, synergistic appetite suppression and metabolic effect. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed an average of 20.9% body weight reduction over 72 weeks — the best clinical data of any approved weight loss medication.
Clinical evidence: The SURMOUNT-1 trial demonstrated 20.9% average total body weight reduction average total body weight reduction with sustained treatment. At Solace, Dr. Flávio applies this evidence to each patient's individual protocol — starting low, titrating slowly, and adjusting based on your labs and response.
Who qualifies: Adults with BMI ≥27 with at least one weight-related condition (hypertension, type 2 diabetes, dyslipidemia), or BMI ≥30 without a condition. Dr. Flávio conducts a full medical review to confirm candidacy. Medication costs and dosing schedules are discussed at your consultation with Dr. Flávio.
FAQ
Get Started
Physician-supervised · Lab work included · Dr. Flávio, DNP, AACC · 12545 New Brittany Blvd, Fort Myers FL 33907
Conveniently located at 12545 New Brittany Blvd — just off US-41 / Tamiami Trail — Fort Myers, FL 33907. Serving McGregor Blvd (33919), Gulf Harbour, Daniels Pkwy (33912), Gateway (33913), Cape Coral, Estero, Bonita Springs, and Naples. Tirzepatide (Mounjaro / Zepbound) weight loss near you in SWFL.